BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10874533)

  • 1. Anti-TSH receptor antibodies in clinical practice.
    Orgiazzi J
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):339-55, vii. PubMed ID: 10874533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of stimulating, function-blocking and growth-blocking anti-TSH receptor antibodies (TRAbs) in GD, Hashimoto's disease and in atrophic thyroiditis.
    Orgiazzi J; Madec AM; Ducottet X
    Ann Endocrinol (Paris); 2003 Feb; 64(1):31-6. PubMed ID: 12707631
    [No Abstract]   [Full Text] [Related]  

  • 3. Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.
    Macchia E; Concetti R; Borgoni F; Cetani F; Fenzi GF; Pinchera A
    Autoimmunity; 1989; 3(2):103-12. PubMed ID: 2577491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TSH-receptor antibodies in thyroid diseases].
    Hasse-Lazar K; Jarzab B; Podwiński A; Waler J; Sprzaczkowska K; Buła G; Skrzypek J
    Pol Arch Med Wewn; 1997 Mar; 97(3):239-51. PubMed ID: 9333770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].
    Fujihira T
    J UOEH; 1989 Dec; 11(4):393-401. PubMed ID: 2575267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
    Kohn LD; Harii N
    Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
    Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
    Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' disease.
    Weetman AP
    N Engl J Med; 2000 Oct; 343(17):1236-48. PubMed ID: 11071676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypothyroidism and endocrine orbitopathy].
    Wiesli P; Knierim M; Knierim C; Schmid C
    Praxis (Bern 1994); 2000 Oct; 89(40):1612-5. PubMed ID: 11081360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
    Ginsberg J; von Westarp C
    CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graves' disease in clinical perspective.
    Ehlers M; Schott M; Allelein S
    Front Biosci (Landmark Ed); 2019 Jan; 24(1):35-47. PubMed ID: 30468646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY; Oh SK; Shong YK; Kim SE; Yoo HY; Lee HK; Koh CS; Min HK
    Autoimmunity; 1990; 8(2):143-7. PubMed ID: 1983330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
    Balázs C
    Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.